|
FY2016
12 months to Apr 3, 2016
|
FY2015
12 months to Mar 29, 2015
|
FY2014
12 months to Mar 30, 2014
|
FY2013
12 months to Mar 31, 2013
|
FY2012
12 months to Apr 1, 2012
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | |||||
| Depreciation | |||||
| Non-cash interest expense | |||||
| Amortization of intangible assets | |||||
| Write-off of in-process research and development | |||||
| Loss on disposal of property and equipment | |||||
| Amortization of debt discount to interest expense | |||||
| Gain on equity investment | |||||
| Loss (gain) on other investment | |||||
| Stock-based compensation expense | |||||
| Contingent consideration adjustment | |||||
| Deferred income tax assets | |||||
| Tax effect of employee benefit plan | |||||
| Excess tax benefit from stock-based compensation | |||||
| Changes in operating assets and liabilities, net of effects of acquisitions: | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Prepaid expenses and other assets | |||||
| Other assets | |||||
| Accounts payable | |||||
| Accrued liabilities | |||||
| Net cash provided by (used in) operating activities | |||||
| Cash flows from investing activities: | |||||
| Acquisitions, net of cash acquired | |||||
| Purchase of property and equipment | |||||
| Purchase of patents | |||||
| Other non-marketable investments | |||||
| Sales and maturities of available-for-sale investments | |||||
| Purchase of available-for-sale investments | |||||
| Proceeds from debt issuance | |||||
| Debt issuance costs | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Payment for purchase of convertible notes hedge | |||||
| Proceeds from sale of warrants | |||||
| Proceeds from the issuance of common stock, net | |||||
| Payments of long-term debt and capital lease obligations | |||||
| Repurchase of restricted stock for taxes | |||||
| Payment of contingent consideration | |||||
| Payment of acquisition holdback | |||||
| Excess tax benefit from stock-based compensation | |||||
| Net cash provided by financing activities | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents: | |||||
| Beginning of period | |||||
| End of period | |||||
| Supplemental disclosures of cash flow information: | |||||
| Cash paid for interest | |||||
| Cash paid (received) for income taxes | |||||
| Noncash investing and financing activities: | |||||
| Unpaid purchases of property and equipment | |||||
| Total contingent consideration from business acquisition | |||||
| Unrealized gain (loss) from available-for-sale investments | |||||
| Non-cash warrant exercises | |||||
| Proceeds receivable from the exercise of stock options | |||||
Loading...